You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

OSELTAMIVIR PHOSPHATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Oseltamivir Phosphate, and when can generic versions of Oseltamivir Phosphate launch?

Oseltamivir Phosphate is a drug marketed by Accord Hlthcare, Alembic, Amneal Pharms, Epic Pharma Llc, Hainan Poly, Hetero Labs Ltd Iii, Invagen Pharms, Laurus, Lupin, Macleods Pharms Ltd, MSN, Natco, Rising, Strides Pharma, Sunshine, Zydus Pharms, Ajanta Pharma Ltd, Alvogen, Amneal Pharms Ny, Aptapharma Inc, Aurobindo Pharma Ltd, Hetero Labs Ltd V, Leading, Oryza, and Teva Pharms Usa. and is included in thirty-one NDAs.

The generic ingredient in OSELTAMIVIR PHOSPHATE is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Oseltamivir Phosphate

A generic version of OSELTAMIVIR PHOSPHATE was approved as oseltamivir phosphate by NATCO on August 3rd, 2016.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OSELTAMIVIR PHOSPHATE?
  • What are the global sales for OSELTAMIVIR PHOSPHATE?
  • What is Average Wholesale Price for OSELTAMIVIR PHOSPHATE?
Drug patent expirations by year for OSELTAMIVIR PHOSPHATE
Recent Clinical Trials for OSELTAMIVIR PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nanjing Zenshine PharmaceuticalsPhase 1
Laboratorios Andromaco S.A.Phase 1
Sunshine Lake Pharma Co., Ltd.Phase 1

See all OSELTAMIVIR PHOSPHATE clinical trials

Pharmacology for OSELTAMIVIR PHOSPHATE
Drug ClassNeuraminidase Inhibitor
Mechanism of ActionNeuraminidase Inhibitors
Medical Subject Heading (MeSH) Categories for OSELTAMIVIR PHOSPHATE
Anatomical Therapeutic Chemical (ATC) Classes for OSELTAMIVIR PHOSPHATE
Paragraph IV (Patent) Challenges for OSELTAMIVIR PHOSPHATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TAMIFLU for Oral Suspension oseltamivir phosphate 6 mg/mL 021246 1 2015-06-18
TAMIFLU Capsules oseltamivir phosphate 30 mg and 45 mg 021087 1 2011-08-02
TAMIFLU Capsules oseltamivir phosphate 75 mg 021087 1 2010-11-15

US Patents and Regulatory Information for OSELTAMIVIR PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunshine OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 212739-001 Mar 4, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 202595-001 Aug 3, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms Ny OSELTAMIVIR PHOSPHATE oseltamivir phosphate FOR SUSPENSION;ORAL 210186-001 Feb 27, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa OSELTAMIVIR PHOSPHATE oseltamivir phosphate FOR SUSPENSION;ORAL 211125-001 Feb 27, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.